JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RESN
4726
DELISTED
Resonant Inc.
RESN
| $39K | ﹤0.01% |
+16,664
| New | +$37K |
2020 Q2
0 quarters
|
|
|
AGS
4727
DELISTED
PlayAGS
AGS
| $38K | ﹤0.01% |
11,448
-303,564
| -96% | -$1.16M |
2018 Q1
9 quarters
|
|
4728
State Street SPDR S&P International Dividend ETF
DWX
$509M
| $38K | ﹤0.01% |
1,139
-50
| -4% | -$1.61K |
2017 Q1
13 quarters
|
|
|
LYRA
4729
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $38K | ﹤0.01% |
+67
| New | +$49K |
2020 Q2
0 quarters
|
|
4730
Transcontinental Realty Investors
TCI
$390M
| $38K | ﹤0.01% |
1,268
-793
| -38% | -$18.3K |
2017 Q4
10 quarters
|
|
4731
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.48B
| $38K | ﹤0.01% |
361
-15
| -4% | -$1.53K |
2015 Q4
18 quarters
|
|
|
EEX
4732
DELISTED
Emerald Holding
EEX
| $37K | ﹤0.01% |
12,109
-91,788
| -88% | -$218K |
2017 Q2
12 quarters
|
|
4733
International General Insurance
IGIC
$1.05B
| $37K | ﹤0.01% |
+5,300
| New | +$34.3K |
2020 Q2
0 quarters
|
|
4734
Immersion
IMMR
$245M
| $37K | ﹤0.01% |
5,968
-18,109
| -75% | -$117K |
2017 Q4
10 quarters
|
|
|
MTA
4735
Metalla Royalty & Streaming
MTA
$859M
| $37K | ﹤0.01% |
+7,073
| New | +$38.6K |
2020 Q2
0 quarters
|
|
|
SACH
4736
Sachem Capital Corp
SACH
$44M
| $37K | ﹤0.01% |
12,513
-68,765
| -85% | -$176K |
2019 Q2
4 quarters
|
|
|
IDEX
4737
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $37K | ﹤0.01% |
148
-1,290
| -90% | -$149K |
2019 Q1
5 quarters
|
|
|
SOLY
4738
DELISTED
Soliton, Inc.
SOLY
| $37K | ﹤0.01% |
4,643
-4,253
| -48% | -$41.8K |
2019 Q2
4 quarters
|
|
|
BLPH
4739
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $37K | ﹤0.01% |
+2,894
| New | +$40.5K |
2020 Q2
0 quarters
|
|
4740
Alliance Resource Partners
ARLP
$3.16B
| $36K | ﹤0.01% |
10,860
-269,841
| -96% | -$925K |
2013 Q2
28 quarters
|
|
4741
iShares MSCI Europe Financials ETF
EUFN
$3.87B
| $36K | ﹤0.01% |
2,530
-147,706
| -98% | -$1.95M |
2016 Q2
16 quarters
|
|
4742
Genco Shipping & Trading
GNK
$1.21B
| $36K | ﹤0.01% |
5,755
-48,291
| -89% | -$280K |
2017 Q4
10 quarters
|
|
4743
Immunic
IMUX
$109M
| $36K | ﹤0.01% |
+294
| New | +$29.9K |
2020 Q2
0 quarters
|
|
4744
Invesco Biotechnology & Genome ETF
PBE
$415M
| $36K | ﹤0.01% |
612
| – | – |
2020 Q1
1 quarter
|
|
4745
Research Frontiers
REFR
$25.4M
| $36K | ﹤0.01% |
+8,924
| New | +$33.1K |
2020 Q2
0 quarters
|
|
4746
ProShares Short 20+ Year Treasury ETF
TBF
$144M
| $36K | ﹤0.01% |
2,300
+300
| +15% | +$4.65K |
2019 Q1
5 quarters
|
|
|
WBK
4747
DELISTED
Westpac Banking Corporation
WBK
| $36K | ﹤0.01% |
2,917
+1,015
| +53% | +$11.1K |
2013 Q2
28 quarters
|
|
4748
EVI Industries
EVI
$248M
| $35K | ﹤0.01% |
1,641
+180
| +12% | +$3.54K |
2017 Q4
10 quarters
|
|
4749
Matinas BioPharma
MTNB
$2.59M
| $35K | ﹤0.01% |
60
| – | – |
2017 Q2
12 quarters
|
|
4750
PrimeEnergy Resources
PNRG
$324M
| $35K | ﹤0.01% |
497
-352
| -41% | -$26.2K |
2019 Q1
5 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.